NEW

Staying Positive During the Pandemic

The good news for patients in need of outpatient surgery is that, across the country, health care providers and policymakers have recognized that elective surgery is not the same thing as optional surgery and are allowing ASCs to remain open to provide this care.

Handling of Explanted Medical Devices Addressed in AORN’s Revised Guideline for Specimen Management

SP professionals must manage explants safely and properly any time a request is made to sterilize an explanted device, such a screw, hip, plate and so on, for return to the patient.

Disinfection Methods – Straightforward or Complicated?

With all the different cleaning, disinfecting and sterilizing processes that go on inside of hospitals, I find disinfection to be the most complex and complicated among them.

Steam Sterilization Standard ST79 Receives Community-Driven Update

After three years, a widely used standard in health care and industry has undergone an important update.

Surgical Specialties, TachoSil Merge to Create Corza Medical

GTCR, a leading private equity firm, announced that its management partnership with Gregory T. Lucier, Corza Health, has simultaneously acquired and merged Surgical Specialties Corporation and the TachoSil Fibrin Sealant Patch to create a new company, Corza Medical. Surgical Specialties is a medical technology company focused on high-performance surgical sutures and ophthalmic knives. TachoSil, previously owned by Takeda Pharmaceutical Company Limited, is a differentiated surgical patch product line used to enable safe and fast bleeding control during surgeries.

The company will be led by Executive Chairman Gregory T. Lucier and Chief Executive Officer Dan Croteau, with a global team of over 1,700 employees supporting clinicians, distributors and medical device companies. Corza Medical will provide health care professionals a platform of surgical technologies with industry-leading brands, including Quill barbed sutures, Sharpoint Plus and Look surgical sutures, Sharpoint ophthalmic knives, and the TachoSil fibrin sealant patch.

“The formation of Corza Medical immediately creates a market-leading, surgical technology business that brings together brands with decades of trust and clinical relevance,” said Lucier. “Our platform of technologies and our commitment to providing exceptional service will help transform surgical outcomes and change the lives of patients around the globe, while providing a foundation for continued, long-term growth.”

In 2019, GTCR partnered with Lucier to create Corza Health. The carve-out of TachoSil and its merger with Surgical Specialties together represent the platform acquisition for the partnership.

“Corza Medical will be laser-focused on bringing differentiated, high-performance technologies to market with world-class service and value,” added Croteau. “We are excited to further build out the Corza Medical portfolio with acquisitions of complementary businesses and technologies, and to become an acquirer of choice in this fragmented market. I look forward to working alongside the GTCR team and Greg on this growth journey.”

The company will be headquartered in Westwood, Massachusetts, and operate in 13 countries throughout North America, Europe and Asia, with manufacturing facilities in the U.S., Mexico, England, Germany and China.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X